EUCTR2020-001301-23-FR进行中（未招募）1 期
Efficacy of Addition of Naproxen in the Treatment of critically ill Patients Hospitalized for COVID-19 Infection / Enacovid Study - ENACOVID
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 584
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •COVID-19 infected patient
- •Age 18 years or older
- •Presence of pneumonia
- •PaO2/FiO2 < 300 mm Hg or SpO2 < 93% in air ambient or need to supplementary oxygen administration in order to maintain SpO2 range in [94-98%] or lung infiltrates > 50%
- •Medical insurance
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 292
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 292
排除标准
- •Presence of do-not-resuscitate order
- •Pregnancy
- •Prisoners
- •Naproxen allergy or intolerance
- •Severe renal failure
研究者
相似试验
招募中
4 期
The effect of Naproxen in recovery and reducing mortality in patients with COVID-19IRCT20200410047009N1Iran University of Medical Sciences101
尚未招募
4 期
Efficacy of naproxen alone or with cinnarizine compared to placebo as an abortive treatment of vestibular migraine: a randomised placebo controlled, double blind studyCTRI/2024/01/061262DrJayantee Kalita
已完成
不适用
decrees pain patient during root canal therapy with consume of analgesicIRCT2013101615041N1Jundishapur university of Medical Science60
已完成
1 期
prevention of orthodontic paiIRCT20140203016466N5Shahid Beheshti University of Medical Sciences30
已完成
2 期
Efficacy of suppository naproxen in prevention of pancreatitisacute pancreatitis.other acute pancreatitisIRCT201105301155N14Behvazan Company324